Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Increases By 243.1%

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) saw a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 1,536,000 shares, a growth of 243.1% from the January 15th total of 447,700 shares. Based on an average daily volume of 2,008,300 shares, the short-interest ratio is currently 0.8 days.

Bayer Aktiengesellschaft Stock Performance

Shares of BAYRY stock opened at $5.70 on Friday. The company has a current ratio of 1.32, a quick ratio of 0.81 and a debt-to-equity ratio of 1.19. The stock has a 50 day simple moving average of $5.24 and a 200-day simple moving average of $6.43. The company has a market cap of $22.40 billion, a price-to-earnings ratio of -21.92 and a beta of 1.04. Bayer Aktiengesellschaft has a 12-month low of $4.79 and a 12-month high of $8.58.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last released its earnings results on Tuesday, November 12th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.10). The business had revenue of $10.96 billion during the quarter. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. On average, equities analysts forecast that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.